NCT06692452 2026-04-01Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Withdrawn
NCT07209163 2025-10-06Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell LymphomaRuijin HospitalPhase 1/2 Not yet recruiting48 enrolled